29 related articles for article (PubMed ID: 12139471)
1. Targeting host-specific metabolic pathways-opportunities and challenges for anti-infective therapy.
Konaklieva MI; Plotkin BJ
Front Mol Biosci; 2024; 11():1338567. PubMed ID: 38455763
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis.
Lee JGH; Genga KR; Pisitsak C; Boyd JH; Leung AKK; Russell JA; Walley KR
Crit Care; 2018 Mar; 22(1):58. PubMed ID: 29510719
[TBL] [Abstract][Full Text] [Related]
3. Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats.
Sharifov OF; Nayyar G; Ternovoy VV; Mishra VK; Litovsky SH; Palgunachari MN; Garber DW; Anantharamaiah GM; Gupta H
Biochem Biophys Res Commun; 2013 Jul; 436(4):705-10. PubMed ID: 23791744
[TBL] [Abstract][Full Text] [Related]
4. Lecithin: cholesterol acyl transfer rate in plasma and its relation to lipid and lipoprotein concentrations in primary hyperlipidemia.
Wallentin L
Atherosclerosis; 1977 Feb; 26(2):233-48. PubMed ID: 189784
[TBL] [Abstract][Full Text] [Related]
5. Mice overexpressing human lecithin: cholesterol acyltransferase are not protected against diet-induced atherosclerosis.
Mehlum A; Muri M; Hagve TA; Solberg LA; Prydz H
APMIS; 1997 Nov; 105(11):861-8. PubMed ID: 9393557
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.
Mehlum A; Staels B; Duverger N; Tailleux A; Castro G; Fievet C; Luc G; Fruchart JC; Olivecrona G; Skretting G
Eur J Biochem; 1995 Jun; 230(2):567-75. PubMed ID: 7607230
[TBL] [Abstract][Full Text] [Related]
7. Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study.
Tani S; Takahashi A; Nagao K; Hirayama A
Heart Vessels; 2016 Jun; 31(6):831-40. PubMed ID: 25894629
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin-lipoprotein complex formation as a factor in atherogenesis: associations with hyperlipidemia and with lecithin:cholesterol acyltransferase activity.
Schwartz YSh; Dushkin MI
Biochemistry (Mosc); 2002 Jul; 67(7):747-52. PubMed ID: 12139471
[TBL] [Abstract][Full Text] [Related]
9. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis.
Santamarina-Fojo S; Lambert G; Hoeg JM; Brewer HB
Curr Opin Lipidol; 2000 Jun; 11(3):267-75. PubMed ID: 10882342
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
Quaschning T; Krane V; Metzger T; Wanner C
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
